Showing results (961-970 of 5,219) with videos related to
Sort By:
Pageof 522
Antiviral Research|December 20, 2021
Niclosamide inhibits hepatitis E virus through suppression of NF-kappaB signallingYunlong Li, Pengfei Li, Qiyu He, et al.Antiviral Research|November 28, 2021
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster modelMaxime Cochin, Franck Touret, Jean-Sélim Driouich, et al.Antiviral Research|October 1, 1987
A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedulesV Carreño, J C Porres, I Mora, et al.Antiviral Research|November 5, 2021
Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitorsEunji Jo, Hyun Kim, Alexander König, et al.Antiviral Research|November 7, 2021
75 years of bovine viral diarrhea virus: Current status and future applications of the use of directed antiviralsBenjamin W NewcomerAntiviral Research|November 21, 2021
2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitorsJianyuan Zhao, Guoning Zhang, Yongxin Zhang, et al.Antiviral Research|November 21, 2021
Identification of Ascomycin against Zika virus infection through screening of natural product libraryLiang Zhou, Jia Zhou, Tongling Chen, et al.Antiviral Research|November 3, 2022
Everolimus reduces BK polyomavirus infection by suppressing its replication and spread of infectionNoriaki Sato, Atsuko Shiraki, Keita P Mori, et al.Antiviral Research|November 3, 2022
Topoisomerase 3b is dispensable for replication of a positive-sense RNA virus--murine coronavirusTianyi Zhang, Shuaikun Su, Valerie Altouma, et al.Antiviral Research|October 18, 2022
Naturally occurring pre-S mutations promote occult HBV infection by affecting pre-S2/S promoter activityHuizhen Sun, Le Chang, Ying Yan, et al.Pageof 522